David King
Member since: Apr '04
Portfolio Manager, New Value Fund at
Putnam Investments
Putnam Investments
4 Opinions
Signal
Opinion
Expert
Chart
TOP PICK
TOP PICK
April 30, 2004
A pure value buy. 9 X trailing PE and 3% yield is intriguing. Headline risk is not as important as were the numbers and up ultimately.
Show full opinionHide full opinion
A pure value buy. 9 X trailing PE and 3% yield is intriguing. Headline risk is not as important as were the numbers and up ultimately.
Financial Services
TOP PICK
TOP PICK
April 30, 2004
Betting on the franchise. Benefits from economic recovery on a global basis. Exciting product line with their iGen3. Still cheap.
Show full opinionHide full opinionBetting on the franchise. Benefits from economic recovery on a global basis. Exciting product line with their iGen3. Still cheap.
misc industrial products
BUY
BUY
April 30, 2004
Attractive. Continuing turnaround in their diagnostic business as well as a better pipeline than some of the other chief pharmaceuticals.
Show full opinionHide full opinionAttractive. Continuing turnaround in their diagnostic business as well as a better pipeline than some of the other chief pharmaceuticals.
biotechnology/pharmaceutical
BUY
BUY
April 30, 2004
A potential takeover play. Has been a bit undermanaged and is very cheap.
Show full opinionHide full opinionA potential takeover play. Has been a bit undermanaged and is very cheap.
biotechnology/pharmaceutical
Comments
Showing 1 to 4
of 4 entries
- «
- ‹
- 1
- ›
- »
© Stockchase Inc.
Stock saved to your watch list successfully.View Watch List
